Articles in section Licensing
| << Joint Venture | 469 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 47 | Next >> |
-
Jazz Licenses Sumitomo’s Narcolepsy Drug for US$50 M Upfront
-
Sanofi Enters Multi-Billion Dollar Antibody Deals with Adagene and IGM
-
Novartis Delves Further into AAV Gene Therapies with US$1.65 B Voyager Deal
-
Endpoint Health and Grifols Collaborate to Develop Antithrombin III for Sepsis
-
Genmab Licenses Synaffix’s Antibody-Drug Conjugate Technologies
-
AstraZeneca Pays US$200 M Upfront for Ionis’ Rare Disease Drug
-
Astellas Partners with Dyno Therapeutics for Gene Therapy Technology
-
Ironwood Begins to Rebolster its Pipeline with Cour’s Rare Disease Drug
-
Aridis Pharmaceuticals Licenses AstraZeneca’s late-stage monoclonal antibody, survatoxumab
-
Biogen Licenses InnoCare’s Orelabrutinib to Strengthen Multiple Sclerosis Presence
RSS